• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 3. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 4. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Phenylpyrrolidines

Introduction to (2R)-2-(3-fluorophenyl)pyrrolidine hydrochloride (CAS No. 1364890-61-8)

(2R)-2-(3-fluorophenyl)pyrrolidine hydrochloride, identified by its CAS number 1364890-61-8, is a significant compound in the field of pharmaceutical chemistry. This compound has garnered attention due to its unique structural properties and potential applications in drug development. The presence of a fluorine atom in the phenyl ring and the pyrrolidine core makes it a promising candidate for further investigation, particularly in the design of novel therapeutic agents.

The< strong>pyrrolidine moiety is a common structural motif in many biologically active molecules, known for its ability to enhance binding affinity and metabolic stability. When combined with a< strong>3-fluorophenyl group, the compound exhibits enhanced lipophilicity and selectivity, which are critical factors in drug design. The hydrochloride salt form of this compound improves its solubility and stability, making it more suitable for various pharmaceutical applications.

Recent studies have highlighted the< strong>potential of (2R)-2-(3-fluorophenyl)pyrrolidine hydrochloride in the development of central nervous system (CNS) drugs. The fluorine atom in the phenyl ring can modulate the pharmacokinetic properties of the molecule, leading to improved blood-brain barrier penetration. This characteristic is particularly valuable in the treatment of neurological disorders where accessing the brain is a major challenge.

In addition to its CNS applications, this compound has shown promise in the treatment of< strong>inflammatory and immunomodulatory disorders. Preclinical studies have demonstrated that it can interact with various biological targets, including enzymes and receptors involved in inflammation pathways. The< strong>3-fluorophenyl group plays a crucial role in these interactions by influencing the electronic properties of the molecule, thereby enhancing its binding affinity.

The< strong>solubility enhancement provided by the hydrochloride salt form is another significant advantage of (2R)-2-(3-fluorophenyl)pyrrolidine hydrochloride. This property facilitates its formulation into various dosage forms, including oral tablets and injectable solutions. Improved solubility also contributes to better bioavailability, which is essential for achieving therapeutic efficacy.

Advances in computational chemistry have further accelerated the development of this compound. Molecular modeling studies have been instrumental in understanding its interactions with biological targets at a molecular level. These studies have provided insights into the binding mode of the< strong>pyrrolidine and< strong>3-fluorophenyl moieties, guiding the optimization of its pharmacological properties.

The< strong>pharmacokinetic profile of (2R)-2-(3-fluorophenyl)pyrrolidine hydrochloride has been extensively studied in preclinical models. Results indicate that it exhibits favorable absorption, distribution, metabolism, and excretion (ADME) properties. The compound demonstrates rapid absorption after oral administration and prolonged half-life, suggesting potential for once-daily dosing regimens.

In conclusion, (2R)-2-(3-fluorophenyl)pyrrolidine hydrochloride (CAS No. 1364890-61-8) is a versatile compound with significant potential in pharmaceutical applications. Its unique structural features, combined with favorable pharmacokinetic properties, make it an attractive candidate for further development. Ongoing research continues to explore its therapeutic applications, particularly in CNS disorders and inflammatory conditions.

• 72216-06-9(2-(4-Fluorophenyl)pyrrolidine)
• 298690-72-9(2-(3-Fluorophenyl)pyrrolidine)
• 298690-89-8((2R)-2-(4-fluorophenyl)pyrrolidine)
• 383130-06-1(2-(3-Fluorophenyl)azepane)
• 1073556-40-7((S)-2-(4-Fluorophenyl)pyrrolidine hydrochloride)
• 920274-04-0((2S)-2-(3-fluorophenyl)pyrrolidine)
• 298690-90-1((2S)-2-(4-fluorophenyl)pyrrolidine)
• 886503-11-3(2-(3,5-difluorophenyl)pyrrolidine)
• 920274-03-9((2R)-2-(3-fluorophenyl)pyrrolidine)
• 77972-92-0(Pyrrolidine, 2-(3-fluorophenyl)-1-methyl-)